AHFS Drug Reassignments
The following describes drug assignments and changes to the AHFS Pharmacologic-Therapeutic Classification©. This is only a partial listing of the AHFS classification system. The full classification, along with a list of drugs covered in AHFS DI and their corresponding classes, is available in the print edition of AHFS and electronically as a dataset that can be licensed. Reproduction, storage on a retrieval system, or transmission of this material or any part thereof in any form or by any means without the express written permission of the American Society of Health-System Pharmacists is prohibited.
Please contact us at ahfs@ashp.org if you have any questions.
AHFS Drug Reassignments
| Drug Name | Active Ingredients | Change Date | Old AHFS Class | New AHFS Class |
|---|---|---|---|---|
| Amtagvi | lifileucel | 07/27/2026 | 26:04 - Cellular Therapy | 26:04 - Cellular Therapy; 10:00 - Antineoplastic Agents |
| Cardizem | dilTIAZem | 06/24/2026 | 24:04.04.24 - Class IV Antiarrhythmics | 24:04.04.24 - Class IV Antiarrhythmics; 24:28 - Calcium-Channel Blocking Agents |
| Calan; Covera-HS; Isoptin SR; Tarka; Verelan; Verelan PM | Verapamil | 06/24/2026 | 24:04.04.24 - Class IV Antiarrhythmics | 24:04.04.24 - Class IV Antiarrhythmics; 24:28 - Calcium-Channel Blocking Agents |
| Cardamyst | etripamil | 06/24/2026 | 24:04.04.24 - Class IV Antiarrhythmics | 24:04.04.24 - Class IV Antiarrhythmics; 24:28 - Calcium-Channel Blocking Agents |
| Pylarify® | Piflufolastat F 18 | 03/11/2026 | 78:00 - Radioactive Agents | 36:92 - Diagnostic Agents, Miscellaneous |
| Vykat XR | diazoxide choline | 02/02/2026 | 28:20.92 - Anorexigenic Agents and Stimulants, Miscellaneous | 28:20.08.92 - Anorexigenic Agents, Miscellaneous |
| Vanrafia | atrasentan | 06/23/2025 | 48:48.12 - Endothelin receptor antagonists | 92:48 - IgA nephropathy |
| Filspari® | sparsentan | 06/23/2025 | 48:48.12 - Endothelin receptor antagonists; 24:32.92 - Renin-Angiotensin-Aldosterone System Inhibitors, Miscellaneous | 92:48 - IgA nephropathy; 24:32.92 - Renin-Angiotensin-Aldosterone System Inhibitors, Miscellaneous |
| Tryngolza | olezarsen | 06/23/2025 | 24:06.92 - Antilipemic Agents, Miscellaneous | 24:06.92 - Antilipemic Agents, Miscellaneous; 92:18 - Antisense Oligonucleotides |
| Lutathera® | lutetium Lu-177 dotatate | 04/07/2025 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 78:00 - Radioactive Agents |
| Syfovre | Pegcetacoplan (Geographic Atrophy) | 04/02/2025 | 52:92 - EENT Drugs, Miscellaneous | 52:44 - Macular Degeneration Agents; 90:20 - Complement Inhibitor Agents |
| Izervay | Avacincaptad Pegol | 04/02/2025 | 52:92 - EENT Drugs, Miscellaneous | 52:44 - Macular Degeneration Agents; 90:20 - Complement Inhibitor Agents |
| Aggrenox; Persantine | Dipyridamole | 02/06/2025 | 36:18 - Cardiac Function | 20:12.18 - Platelet-aggregation Inhibitors; 36:18 - Cardiac Function |
| N/A | Benzodiazepines General Statement | 11/26/2024 | 28:24.08 - Benzodiazepines; 28:12.08 - Benzodiazepines | 28:24.08 - Benzodiazepines; 28:12.08 - Benzodiazepines |
| Orabase-B; Cepacol; Cetacaine; Dermoplast | Benzocaine (EENT) | 10/29/2024 | 52:16 - Local Anesthetics | 52:16 - Local Anesthetics; 84:08 - Antipruritics and Local Anesthetics |
| Neosporin Ophthalmic Ointment | Bacitracin (EENT) | 10/29/2024 | 52:04.04 - Antibacterials; 84:04.04 - Antibacterials | 52:04.04 - Antibacterials; 84:04.04 - Antibacterials; 8:12.28.08 - Bacitracins |
| Neosporin | Bacitracin (Topical) | 10/29/2024 | 84:04.04 - Antibacterials; 52:04.04 - Antibacterials | 84:04.04 - Antibacterials; 52:04.04 - Antibacterials; 8:12.28.08 - Bacitracins |
| Lotensin; Lotrel | Benazepril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.44.04 - Angiotensin-Converting Enzyme Inhibitors | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| Rylaze | Asparaginase Erwinia Chrysanthemi (Recombinant) | 10/29/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 44:00 - Enzymes |
| Brovana | Arformoterol | 10/29/2024 | 12:12.08.12 - Selective beta-2-Adrenergic Agonists | 12:12.08.12 - Selective beta-2-Adrenergic Agonists; 48:12.04.12 - Selective beta-2-Adrenergic Agonists |
| Otezla; Otezla Starter Pack | Apremilast | 10/29/2024 | 90:24.24.92 - Phosphodiesterase-4 Inhibitors, Miscellaneous; 92:20 - Immunomodulatory Agents; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 90:24.24.92 - Phosphodiesterase-4 Inhibitors, Miscellaneous |
| Campath | Alemtuzumab | 10/29/2024 | 10:00 - Antineoplastic Agents; 92:20 - Immunomodulatory Agents; 90:04.04 - Monoclonal Antibodies | 10:00 - Antineoplastic Agents; 90:04.04 - Monoclonal Antibodies |
| Duaklir Pressair; Tudorza Pressair | Aclidinium | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 48:12.08 - Anticholinergic Agents |
| Dysport | AbobotulinumtoxinA | 10/29/2024 | 12:20.20.24 - Botulinum toxins; 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.20.24 - Botulinum toxins |
| Orencia | Abatacept | 10/29/2024 | 90:24.92 - Disease-modifying Antirheumatic Drugs, Miscellaneous; 92:20 - Immunomodulatory Agents | 90:24.92 - Disease-modifying Antirheumatic Drugs, Miscellaneous |
| LamISIL AT; LamISIL AT Continuous Spray; LamISIL AT Spray Pump | Terbinafine | 10/29/2024 | 84:04.08.04 - Allylamines | 84:04.08.04 - Allylamines; 8:14.04 - Allylamines |
| Advicor; Niacor; Niaspan | Niacin | 10/29/2024 | 24:06.92 - Antilipemic Agents, Miscellaneous | 24:06.92 - Antilipemic Agents, Miscellaneous; 88:08 - Vitamin B Complex |
| Bactine First Aid Antibiotic Plus Anesthetic; Neosporin; Neosporin G.U. Irrigant; Spectrocin Plus; Triple Antibiotic Extra | Neomycin (Topical) | 10/29/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:12.02 - Aminoglycosides; 52:04.04 - Antibacterials |
| Calan; Covera-HS; Isoptin SR; Tarka; Verelan; Verelan PM | Verapamil | 10/29/2024 | 24:04.04.24 - Class IV Antiarrhythmics; 24:28 - Calcium-Channel Blocking Agents | 24:04.04.24 - Class IV Antiarrhythmics |
| Tyrvaya | Varenicline (nasal) | 10/29/2024 | 52:92 - EENT Drugs, Miscellaneous | 52:92 - EENT Drugs, Miscellaneous; 12:02 - Smoking Cessation Agents |
| Diovan; Exforge | Valsartan | 10/29/2024 | 24:32.08 - Angiotensin II Receptor Antagonists; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.08 - Angiotensin II Receptor Antagonists |
| Vistogard; Xuriden | Uridine Triacetate | 10/29/2024 | 91:04.32 - Fluoropyrimidine antidote; 92:92 - Other Miscellaneous Therapeutic Agents | 91:04.32 - Fluoropyrimidine antidote |
| Carbamide | Urea | 10/29/2024 | 40:28.12 - Osmotic Diuretics | 40:28.12 - Osmotic Diuretics; 24:36.12 - Osmotic Diuretics; 52:40.24 - Osmotic Agents; 84:28 - Keratolytic Agents |
| Aqua Care; Carmol; Gordon's Urea; Nutraplus; Rea-Lo; Ultra Mide; Ureacin | Urea | 10/29/2024 | 84:28 - Keratolytic Agents | 84:28 - Keratolytic Agents; 24:36.12 - Osmotic Diuretics; 40:28.12 - Osmotic Diuretics; 52:40.24 - Osmotic Agents |
| Anoro Ellipta | Umeclidinium Bromide and Vilanterol Trifenatate | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 12:12.08.12 - Selective beta-2-Adrenergic Agonists |
| Incruse Ellipta; Trelegy Ellipta | Umeclidinium | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 48:12.08 - Anticholinergic Agents |
| Trihexyphenidyl | 10/29/2024 | 28:36.08 - Anticholinergic Agents | 28:36.08 - Anticholinergic Agents; 12:08.04 - Antiparkinsonian Agents | |
| Aristocort; Flutex; Kenalog; Myco II; Mytrex; N.T.A. Cream; NGT; Triacet; Tri-Statin II | Triamcinolone | 10/29/2024 | 84:06.08 - Corticosteroids | 84:06.08 - Corticosteroids; 48:10.08 - Corticosteroids; 52:08.08 - Corticosteroids; 68:04 - Adrenals |
| Avita; Renova Emollient; Retin-A; Retin-A Micro | Tretinoin | 10/29/2024 | 84:16 - Cell Stimulants and Proliferants | 84:16 - Cell Stimulants and Proliferants; 10:00 - Antineoplastic Agents |
| Lysteda; Cyklokapron | Tranexamic acid | 10/29/2024 | 20:28.16 - Hemostatics | |
| Mavik; Tarka | Trandolapril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| AK-Tob; TobraDex; Tobrex; Zylet | Tobramycin | 10/29/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.02 - Aminoglycosides |
| Mounjaro | Tirzepatide | 10/29/2024 | 68:20.06 - Incretin Mimetics | 68:20.06 - Incretin Mimetics; 28:20.08.92 - Anorexigenic Agents, Miscellaneous |
| Betimol; Cosopt Ocumeter Plus | Timolol | 10/29/2024 | 52:40.08 - beta-Adrenergic Blocking Agents | 52:40.08 - beta-Adrenergic Blocking Agents; 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents; 28:32.92 - Antimigraine Agents, Miscellaneous; |
| Thalomid | Thalidomide | 10/29/2024 | 92:20 - Immunomodulatory Agents | 92:20 - Immunomodulatory Agents; 10:00 - Antineoplastic Agents |
| Tezspire | Tezepelumab-ekko | 10/29/2024 | 48:10.20 - Interleukin Antagonists; 8:18.24 - Monoclonal Antibodies | 48:10.20 - Interleukin Antagonists |
| Symdeko | Tezacaftor and Ivacaftor | 10/29/2024 | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors; 48:14.12 - Cystic Fibrosis Transmembrane Conductance Regulator Potentiators |
| Helidac Therapy; Pylera; Sumycin | Tetracycline (systemic) | 10/29/2024 | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 56:28 - Antiulcer Agents and Acid Suppressants; 84:04.04 - Antibacterials |
| Tetracycline | 10/29/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 56:28 - Antiulcer Agents and Acid Suppressants | |
| Altacaine; Tetcaine; Tetravisc | Tetracaine | 10/29/2024 | 52:16 - Local Anesthetics | 52:16 - Local Anesthetics; 72:00 - Local Anesthetics |
| Androderm; AndroGel; Aveed; Axiron; Delatestryl; Depo-Testosterone; Fortesta; Jatenzo; Natesto; Striant; Testim; Testopel; Vogelxo; Tlando; Xyosted | Testosterone | 10/29/2024 | 68:08 - Androgens | 68:08 - Androgens; 68:18.04 - Antigonadotropins |
| Micardis; Micardis HCT; Twynsta | Telmisartan | 10/29/2024 | 24:32.08 - Angiotensin II Receptor Antagonists; 24:08.44.08 - Angiotensin II Receptor Antagonists | 24:32.08 - Angiotensin II Receptor Antagonists |
| Protopic | Tacrolimus | 10/29/2024 | 84:06.28 - Immunomodulatory Agents | 84:06.28 - Immunomodulatory Agents; 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous |
| Astagraf; Envarsus; Prograf | Tacrolimus | 10/29/2024 | 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous | 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous; 84:06.28 - Immunomodulatory Agents |
| Aldactazide; Aldactone | Spironolactone | 10/29/2024 | 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 24:36.16 - Potassium-sparing Diuretics | 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 24:36.16 - Potassium-sparing Diuretics; 40:28.16 - Potassium-sparing Diuretics |
| Filspari | Sparsentan | 10/29/2024 | 48:48.12 - Endothelin receptor antagonists | 48:48.12 - Endothelin receptor antagonists; 24:32.92 - Renin-Angiotensin-Aldosterone System Inhibitors, Miscellaneous |
| Vosevi | Sofosbuvir, Velpatasvir, Voxilaprevir | 10/29/2024 | 8:18.40.16 - HCV Polymerase Inhibitors | 8:18.40.16 - HCV Polymerase Inhibitors; 8:18.40.20 - HCV Protease Inhibitors; 8:18.40.24 - HCV Replication Complex Inhibitors |
| Nithiodote | Sodium Thiosulfate | 10/29/2024 | 91:04.24 - Cyanide antidotes | 91:04.24 - Cyanide antidotes; 84:04.08.92 - Antifungals, Miscellaneous |
| Hyftor | Sirolimus | 10/29/2024 | 84:06.28 - Immunomodulatory Agents | 84:06.28 - Immunomodulatory Agents; 90:28.24.92 - mTOR Inhibitors, Miscellaneous |
| Viagra | Sildenafil | 10/29/2024 | 24:08.12 - Phosphodiesterase Type 5 Inhibitors | 24:08.12 - Phosphodiesterase Type 5 Inhibitors; 48:48.24 - Phosphodiesterase Type 5 Inhibitors |
| Liqrev; Revatio | Sildenafil Citrate (Pulmonary Hypertension) | 10/29/2024 | 48:48.24 - Phosphodiesterase Type 5 Inhibitors | 48:48.24 - Phosphodiesterase Type 5 Inhibitors; 24:08.12 - Phosphodiesterase Type 5 Inhibitors |
| Imcivree | Setmelanotide | 10/29/2024 | 68:48 - Melanocortin Receptor Agonists; 28:92 - Central Nervous System Agents, Miscellaneous | 68:48 - Melanocortin Receptor Agonists |
| Ozempic; Rybelsus | Semaglutide | 10/29/2024 | 68:20.06 - Incretin Mimetics | 68:20.06 - Incretin Mimetics; 28:20.08.92 - Anorexigenic Agents, Miscellaneous |
| Isopto Hyoscine; Murocoll-2 | Scopolamine | 10/29/2024 | 52:24 - Mydriatics | 52:24 - Mydriatics; 12:08.08 - Antimuscarinics/Antispasmodics; 56:22.92 - Antiemetics, Miscellaneous |
| Salicylates General Statement | 10/29/2024 | 28:08.04.24 - Salicylates; 28:32.92 - Antimigraine Agents, Miscellaneous | 28:08.04.24 - Salicylates | |
| Opzelura | Ruxolitinib Phosphate | 10/29/2024 | 84:06.16 - Janus Kinase Inhibitors | 84:06.16 - Janus Kinase Inhibitors; 10:00 - Antineoplastic Agents |
| Myobloc | RimabotulinumtoxinB | 10/29/2024 | 12:20.20.24 - Botulinum toxins; 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.20.24 - Botulinum toxins |
| Yupelri | Revefenacin | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 48:12.08 - Anticholinergic Agents |
| Altace | Ramipril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| Phenadoz; Phenergan; Promethegan | Promethazine | 10/29/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous; 56:22.92 - Antiemetics, Miscellaneous | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous; 56:22.92 - Antiemetics, Miscellaneous; 56:22.12 - Dopamine Receptor Antagonists |
| Fallback Solo; Implanon; Kyleena; Liletta; Micronor; Mirena; Nexplanon; Skyla; Slynd | Progestins | 10/29/2024 | 68:12 - Contraceptives; 68:32 - Progestins | 68:12 - Contraceptives; 68:32 - Progestins; 68:18.04 - Antigonadotropins |
| Salagen | Pilocarpine | 10/29/2024 | 12:04 - Parasympathomimetic (Cholinergic) Agents | 12:04 - Parasympathomimetic (Cholinergic) Agents; 52:40.20 - Miotics |
| Children's Sudafed PE Cold & Cough; Preparation H; Sudafed PE Cold + Cough Caplets; Vazculep | Phenylephrine | 10/29/2024 | 12:12.04 - alpha-Adrenergic Agonists | 12:12.04 - alpha-Adrenergic Agonists; 52:32 - Vasoconstrictors; 52:24 - Mydriatics |
| Phentolamine Mesylate for Injection | Phentolamine | 10/29/2024 | 12:16.04.04 - Non-selective alpha-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 12:16.04.04 - Non-selective alpha-Adrenergic Blocking Agents |
| Dibenzyline | Phenoxybenzamine | 10/29/2024 | 12:16.04.04 - Non-selective alpha-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 12:16.04.04 - Non-selective alpha-Adrenergic Blocking Agents |
| Aceon; Prestalia | Perindopril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.44.04 - Angiotensin-Converting Enzyme Inhibitors | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| Pegasys; PegIntron | Peginterferon Alfa (Antiviral) | 10/29/2024 | 8:18.20 - Interferons; 92:20 - Immunomodulatory Agents; 10:00 - Antineoplastic Agents | 8:18.20 - Interferons; 90:04.12 - Interferons; 10:00 - Antineoplastic Agents |
| N/A | Opium | 10/29/2024 | 28:08.08 - Opioid Agonists | 28:08.08 - Opioid Agonists; 56:08 - Antidiarrhea Agents |
| N/A | Opioid Agonists General Statement | 10/29/2024 | 28:08.08 - Opioid Agonists; 28:32.92 - Antimigraine Agents, Miscellaneous | 28:08.08 - Opioid Agonists |
| Botox; Botox Cosmetic | OnabotulinumtoxinA | 10/29/2024 | 12:20.20.24 - Botulinum toxins; 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.20.24 - Botulinum toxins |
| Stiolto Respimat; Striverdi Respimat | Olodaterol | 10/29/2024 | 12:12.08.12 - Selective beta-2-Adrenergic Agonists | 12:12.08.12 - Selective beta-2-Adrenergic Agonists; 48:12.04.12 - Selective beta-2-Adrenergic Agonists |
| Azor; Benicar; Tribenzor | Olmesartan | 10/29/2024 | 24:32.08 - Angiotensin II Receptor Antagonists; 24:08.44.08 - Angiotensin II Receptor Antagonists | 24:32.08 - Angiotensin II Receptor Antagonists |
| Symbyax; ZyPREXA | OLANZapine | 10/29/2024 | 28:16.08.04 - Atypical Antipsychotics; 28:28 - Antimanic Agents | 28:16.08.04 - Atypical Antipsychotics; 28:28 - Antimanic Agents; 56:22.92 - Antiemetics, Miscellaneous |
| Mycostatin; Mykacet; Nystat-Rx; Nystop; Pedi-Dri | Nystatin | 10/29/2024 | 84:04.08.28 - Polyenes | 84:04.08.28 - Polyenes; 8:14.28 - Polyenes |
| Rectiv | Nitroglycerin | 10/29/2024 | 84:24.12 - Basic Ointments and Protectants | 84:24.12 - Basic Ointments and Protectants; 24:08.08 - Nitrates and Nitrites |
| Sular | Nisoldipine | 10/29/2024 | 24:28.08 - Dihydropyridines; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:28.08 - Dihydropyridines |
| Nimotop | niMODipine | 10/29/2024 | 24:28.08 - Dihydropyridines; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:28.08 - Dihydropyridines |
| Cardene I.V.; Cardene SR | niCARdipine | 10/29/2024 | 24:28.08 - Dihydropyridines; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:28.08 - Dihydropyridines |
| Slo-Niacin | Niacin/Niacinamide | 10/29/2024 | 88:08 - Vitamin B Complex | 88:08 - Vitamin B Complex; 24:06.92 - Antilipemic Agents, Miscellaneous |
| Bunavail; Cassipa; Evzio; Narcan; Suboxone; Zubsolv | Naloxone | 10/29/2024 | 28:10 - Opioid Antagonists | 28:10 - Opioid Antagonists; 91:00 - Antidote Therapeutics |
| Moxeza; Vigamox | Moxifloxacin | 10/29/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.18 - Quinolones |
| Bafiertam | Monomethyl fumarate | 10/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.08 - Fumarates |
| Elocon | Mometasone | 10/29/2024 | 84:06.08 - Corticosteroids | 84:06.08 - Corticosteroids; 68:04 - Adrenals; 48:10.08 - Corticosteroids; 52:08.08 - Corticosteroids |
| Moexipril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors | |
| Dynacin; Minocin; Minolira; Solodyn; Ximino | Minocycline | 10/29/2024 | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 84:04.04 - Antibacterials; 52:04.04 - Antibacterials |
| Amzeeq; Zilxi | Minocycline (Topical) | 10/29/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 52:04.04 - Antibacterials |
| Arestin | Minocycline (EENT) | 10/29/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 84:04.04 - Antibacterials |
| Osmitrol; Osmitrol 5% | Mannitol (Diagnostic) | 10/29/2024 | 36:40 - Kidney Function | 36:40 - Kidney Function; 24:36.12 - Osmotic Diuretics; 40:28.12 - Osmotic Diuretics; 40:36 - Irrigating Solutions; 52:40.24 - Osmotic Agents |
| Magnesium Sulfate Injection; Magnesium Sulfate in 5% Dextrose Injection | Magnesium Sulfate | 10/29/2024 | 28:12.92 - Anticonvulsants, Miscellaneous; 24:04.04.92 - Antiarrhythmics, Miscellaneous | 28:12.92 - Anticonvulsants, Miscellaneous; 24:04.04.92 - Antiarrhythmics, Miscellaneous; 91:00 - Antidote Therapeutics |
| Lutathera | Lutetium Lu-177 Dotatate | 10/29/2024 | 10:00 - Antineoplastic Agents; 78:00 - Radioactive Agents | 10:00 - Antineoplastic Agents |
| Reblozyl | luspatercept | 10/29/2024 | 20:16 - Hematopoietic Agents | 20:16 - Hematopoietic Agents; 20:04 - Antianemia Drugs |
| Prinivil; Prinzide; Zestoretic; Zestril | Lisinopril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| levoFLOXacin (EENT) | 10/29/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.18 - Quinolones | |
| Arava | Leflunomide | 10/29/2024 | 90:24.04 - Monocarboxylic Acid Amide Agents; 92:20 - Immunomodulatory Agents | 90:24.04 - Monocarboxylic Acid Amide Agents |
| Acular; Acular LS; Acular PF | Ketorolac | 10/29/2024 | 52:08.20 - Nonsteroidal Anti-inflammatory Agents | 52:08.20 - Nonsteroidal Anti-inflammatory Agents; 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Extina; Ketoconazole Cream; Nizoral; Nizoral A-D; Xolegel | Ketoconazole | 10/29/2024 | 84:04.08.08 - Azoles | 84:04.08.08 - Azoles; 8:14.08 - Azoles |
| Ketalar | Ketamine | 10/29/2024 | 28:04.08 - Non-barbiturates | 28:04.08 - Non-barbiturates; 28:16.04.92 - Antidepressants, Miscellaneous |
| Azedra | Iobenguane I-131 | 10/29/2024 | 10:00 - Antineoplastic Agents; 78:00 - Radioactive Agents; 36:68 - Roentgenography | 10:00 - Antineoplastic Agents |
| Xeomin | IncobotulinumtoxinA | 10/29/2024 | 12:20.20.24 - Botulinum toxins; 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.20.24 - Botulinum toxins |
| Anaspaz; Cystospaz; Levbid; Levsin; NuLev; Symax DuoTab; Symax FasTab; Symax SL; Symax SR | Hyoscyamine | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics; 91:00 - Antidote Therapeutics | 12:08.08 - Antimuscarinics/Antispasmodics; 91:00 - Antidote Therapeutics; 48:12.08 - Anticholinergic Agents |
| Plaquenil | Hydroxychloroquine | 10/29/2024 | 8:30.08 - Antimalarials; 92:20 - Immunomodulatory Agents | 8:30.08 - Antimalarials; 92:20 - Immunomodulatory Agents; 90:24 - Disease-modifying Antirheumatic Drugs |
| Bevespi; Cuvposa; Glyrx-PF; Lonhala, Robinul, Seebri, Utibron | Glycopyrrolate | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics; 84:12 - Astringents | 12:08.08 - Antimuscarinics/Antispasmodics; 84:12 - Astringents; 48:12.08 - Anticholinergic Agents |
| Garamycin Cream; Garamycin Ointment | Gentamicin Sulfate (Topical) | 10/29/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:12.02 - Aminoglycosides; 52:04.04 - Antibacterials |
| Gentak; Gentasol; Ocu-Mycin; Pred-G Liquifilm; Pred-G S.O.P. | Gentamicin Sulfate (EENT) | 10/29/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.02 - Aminoglycosides; 84:04.04 - Antibacterials |
| Zirgan | Ganciclovir | 10/29/2024 | 52:04.20 - Antivirals | 52:04.20 - Antivirals; 8:18.32 - Nucleosides and Nucleotides |
| Fosinopril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors | |
| Advair Diskus; Advair HFA; Flovent Diskus; Arnuity Ellipta; Flovent HFA; Trelegy Ellipta; Wixela Inhub | Fluticasone | 10/29/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 48:10.08 - Corticosteroids; 52:08.08 - Corticosteroids |
| Flurbiprofen | 10/29/2024 | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors; 52:08.20 - Nonsteroidal Anti-inflammatory Agents | |
| Beqvez | Fidanacogene elaparvovec | 10/29/2024 | 26:12 - Gene Therapy | 26:12 - Gene Therapy; 20:28.16 - Hemostatics |
| Plendil | Felodipine | 10/29/2024 | 24:28.08 - Dihydropyridines; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:28.08 - Dihydropyridines |
| Afinitor; Afinitor Disperz; Zortress | Everolimus | 10/29/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 90:00 - Immunomodulatory Agents |
| Vaseretic; Vasotec | Enalapril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.44.04 - Angiotensin-Converting Enzyme Inhibitors | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| Trikafta | Elexacaftor, Tezacaftor, and Ivacaftor | 10/29/2024 | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors; 48:14.12 - Cystic Fibrosis Transmembrane Conductance Regulator Potentiators |
| SINEquan; SINEquan Oral Concentrate | Doxepin (systemic) | 10/29/2024 | 28:16.04.28 - Tricyclics and Other Norepinephrine-reuptake Inhibitors | 28:16.04.28 - Tricyclics and Other Norepinephrine-reuptake Inhibitors; 84:08 - Antipruritics and Local Anesthetics |
| Prudoxin; Zonalon | Doxepin (topical) | 10/29/2024 | 84:08 - Antipruritics and Local Anesthetics | 84:08 - Antipruritics and Local Anesthetics; 28:16.04.28 - Tricyclics and Other Norepinephrine-reuptake Inhibitors |
| Aggrenox; Persantine | Dipyridamole | 10/29/2024 | 36:18 - Cardiac Function; 20:12.18 - Platelet-aggregation Inhibitors | 36:18 - Cardiac Function |
| Cardizem | dilTIAZem | 10/29/2024 | 24:04.04.24 - Class IV Antiarrhythmics; 24:28 - Calcium-Channel Blocking Agents | 24:04.04.24 - Class IV Antiarrhythmics |
| Solaraze | Diclofenac | 10/29/2024 | 84:06.20 - Nonsteroidal Anti-inflammatory Agents | 84:06.20 - Nonsteroidal Anti-inflammatory Agents; 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Decadron; DexaJect; Dexasone; Dexium; Dextenza | Dexamethasone | 10/29/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 52:08.08 - Corticosteroids |
| Daxxify | DaxibotulinumtoxinA-lanm | 10/29/2024 | 12:20.20.24 - Botulinum toxins; 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.20.24 - Botulinum toxins |
| Symtuza | Darunavir, Cobicistat, Emtricitabine, Tenofovir Alafenamide | 10/29/2024 | 8:18.08.08 - HIV Protease Inhibitors | 8:18.08.08 - HIV Protease Inhibitors; 8:18.08.20 - HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors |
| Dapsone Tablets | Dapsone (Systemic) | 10/29/2024 | 8:16.08 - Antileprosy Agents; 84:04.04 - Antibacterials | 8:16.08 - Antileprosy Agents; 84:04.04 - Antibacterials; 8:30.92 - Antiprotozoals, Miscellaneous; 84:92 - Skin and Mucous Membrane Agents |
| Aczone | Dapsone (Topical) | 10/29/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:16.08 - Antileprosy Agents; 8:30.92 - Antiprotozoals, Miscellaneous; 84:92 - Skin and Mucous Membrane Agents |
| Jesduvroq | Daprodustat | 10/29/2024 | 20:16 - Hematopoietic Agents | 20:16 - Hematopoietic Agents; 20:04 - Antianemia Drugs |
| Crolom; Nasalcrom | Cromolyn | 10/29/2024 | 52:02 - Antiallergic Agents; 52:92 - EENT Drugs, Miscellaneous | 52:02 - Antiallergic Agents; 52:92 - EENT Drugs, Miscellaneous; 48:10.32 - Mast-cell Stabilizers |
| Prevpac; Biaxin Filmtab; Biaxin Granules | Clarithromycin | 10/29/2024 | 8:12.12.08 - Other Macrolides; 8:16.04 - Antituberculosis Agents; 56:28 - Antiulcer Agents and Acid Suppressants | 8:12.12.08 - Other Macrolides; 8:16.04 - Antituberculosis Agents; 56:28 - Antiulcer Agents and Acid Suppressants; 56:28.18 - Potassium-competitive Acid Blockers |
| Leustatin | Cladribine | 10/29/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 90:04.20 - Antimetabolites |
| Alvesco | Ciclesonide | 10/29/2024 | 68:04 - Adrenals; 52:08.08 - Corticosteroids | 68:04 - Adrenals; 52:08.08 - Corticosteroids; 68:04 - Adrenals; 52:08.08 - Corticosteroids; 48:10.08 - Corticosteroids |
| Iheezo | Chloroprocaine Hydrochloride (EENT) | 10/29/2024 | 52:16 - Local Anesthetics | 52:16 - Local Anesthetics; 72:00 - Local Anesthetics |
| Paroex; Peridex; PerioChip; PerioGard; PerioGard Alcohol Free | Chlorhexidine (EENT) | 10/29/2024 | 52:04.24 - Astringents; 84:04.16 - Astringents, Anti-infective | 52:04.24 - Astringents; 84:04.16 - Astringents, Anti-infective; 8:30.04 - Amebicides |
| Captopril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors | |
| Tecartus | Brexucabtagene Autoleucel | 10/29/2024 | 26:12 - Gene Therapy | 26:12 - Gene Therapy; 10:00 - Antineoplastic Agents |
| Biktarvy | Bictegravir, Emtracitabine, Tenofovir Alafenamide | 10/29/2024 | 8:18.08.12 - HIV Integrase Inhibitors | 8:18.08.12 - HIV Integrase Inhibitors; 8:18.08.20 - HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors |
| Betoptic S | Betaxolol (EENT) | 10/29/2024 | 52:40.08 - beta-Adrenergic Blocking Agents | 52:40.08 - beta-Adrenergic Blocking Agents; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 24:20 - beta-Adrenergic Blocking Agents |
| Cogentin | Benztropine | 10/29/2024 | 28:36.08 - Anticholinergic Agents | 28:36.08 - Anticholinergic Agents; 12:08.04 - Antiparkinsonian Agents |
| Android; Methitest; Testred | methylTESTOSTERone | 09/24/2024 | 68:08 - Androgens | 68:08 - Androgens; 68:18.04 - Antigonadotropins |
| Orgovyx | Relugolix | 09/24/2024 | 68:18.04 - Antigonadotropins | 68:18.04 - Antigonadotropins; 10:00 - Antineoplastic Agents |
| Compazine; Compro; Prochlorperazine Suppositories | Prochlorperazine (Antiemetic) | 09/24/2024 | 56:22.08 - Antihistamines | 56:22.08 - Antihistamines; 28:16.08.24 - Phenothiazines |
| Orapred; Pediapred; Prelone Syrup | prednisoLONE | 09/24/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 52:08.08 - Corticosteroids |
| Pred-G; Pred Mild; Pred Forte; Inflamase Mild; AK-Pred; Blephamide; Econopred Plus | prednisoLONE (EENT) | 09/24/2024 | 52:08.08 - Corticosteroids | 52:08.08 - Corticosteroids; 68:04 - Adrenals |
| Cortisporin Otic Solution; Polytrim; Casporyn; Maxitrol | Polymyxin B | 09/24/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.28.28 - Polymyxins; 84:04.04 - Antibacterials |
| Isopto Carpine; Pilopine HS | Pilocarpine | 09/24/2024 | 52:40.20 - Miotics | 52:40.20 - Miotics; 12:04 - Parasympathomimetic (Cholinergic) Agents |
| AK-Dilate; Ocu-Phrin; Neo-Synephrine | Phenylephrine (Mydriatics) | 09/24/2024 | 52:24 - Mydriatics | 52:24 - Mydriatics; 12:12.04 - alpha-Adrenergic Agonists; 52:32 - Vasoconstrictors |
| Murocoll; Cyclomydril; Dristan; Neo-Synephrine; Mydfrin | Phenylephrine (Vasoconstrictor) | 09/24/2024 | 52:32 - Vasoconstrictors | 52:32 - Vasoconstrictors; 12:12.04 - alpha-Adrenergic Agonists; 52:24 - Mydriatics |
| Luminal Sodium | PHENobarbital (Sedative) | 09/24/2024 | 28:24.04 - Barbiturates | 28:24.04 - Barbiturates; 28:12.04 - Barbiturates |
| Luminal Sodium; PHENobarbital Sodium Injection | PHENobarbital (Anticonvulsant) | 09/24/2024 | 28:12.04 - Barbiturates | 28:12.04 - Barbiturates; 28:24.04 - Barbiturates |
| Sylatron | Peginterferon Alfa | 09/24/2024 | 10:00 - Antineoplastic Agents; 8:18.20 - Interferons; 92:20 - Immunomodulatory Agents | 10:00 - Antineoplastic Agents; 8:18.20 - Interferons; 92:20 - Immunomodulatory Agents; 90:04.12 - Interferons |
| Syfovre | Pegcetacoplan | 09/24/2024 | 52:44 - Macular Degeneration Agents | 52:44 - Macular Degeneration Agents; 90:20 - Complement Inhibitor Agents |
| Upneeq; Visine L.R. Eye Drops; Zicam Intense Sinus Relief Nasal Gel; Afrin No Drip Original 12 Hour Pump Mist | Oxymetazoline Hydrochloride (EENT) | 09/24/2024 | 52:32 - Vasoconstrictors | 52:32 - Vasoconstrictors; 84:06.24 - Adrenergic Agonists |
| Oxandrolone | 09/24/2024 | 68:08 - Androgens | 68:08 - Androgens; 68:18.04 - Antigonadotropins | |
| Paregoric | Opium Preparations | 09/24/2024 | 56:08 - Antidiarrhea Agents | 56:08 - Antidiarrhea Agents; 28:08.08 - Opioid Agonists |
| Ocuflox | Ofloxacin | 09/24/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.18 - Quinolones |
| Axid; Axid AR Acid Reducer; Axid Pulvules | Nizatidine | 09/24/2024 | 56:28.12 - Histamine H2-Antagonists | 56:28.12 - Histamine H2-Antagonists; 4:92 - Other Antihistamines |
| NitroMist; Nitrolingual; Nitro-Time; GoNitro; Nitrostat; Nitro-Dur; Minitran | Nitroglycerin (systemic) | 09/24/2024 | 24:08.08 - Nitrates and Nitrites; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 24:08.08 - Nitrates and Nitrites; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous; 84:24.12 - Basic Ointments and Protectants |
| Neosporin Ophthalmic Solution; Maxitrol | Neomycin (EENT) | 09/24/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.02 - Aminoglycosides; 84:04.04 - Antibacterials |
| Asmanex HFA; Asmanex Twisthaler; Dulera | Mometasone Furoate (Oral Inhalation) | 09/24/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 48:10.08 - Corticosteroids; 52:08.08 - Corticosteroids; 84:06.08 - Corticosteroids |
| Flagyl | metroNIDAZOLE | 09/24/2024 | 8:30.16.92 - Nitroimidazole Derivatives, Miscellaneous; 8:30.04 - Amebicides; 56:28 - Antiulcer Agents and Acid Suppressants; 84:04.04 - Antibacterials; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 8:30.16.92 - Nitroimidazole Derivatives, Miscellaneous; 8:30.04 - Amebicides; 56:28 - Antiulcer Agents and Acid Suppressants; 84:04.04 - Antibacterials |
| MetroCream; MetroGel; MetroGel-Vaginal; MetroLotion; Noritate; Vandazole | metroNIDAZOLE (Topical) | 09/24/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:30.16.92 - Nitroimidazole Derivatives, Miscellaneous; 8:30.04 - Amebicides; 56:28 - Antiulcer Agents and Acid Suppressants |
| Antivert; Bonine; Dramamine Less Drowsy; Meni-D | Meclizine | 09/24/2024 | 56:22.08 - Antihistamines | 56:22.08 - Antihistamines; 4:04 - First Generation Antihistamines |
| Alomide | Lodoxamide | 09/24/2024 | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines; 48:10.32 - Mast-cell Stabilizers |
| Saxenda; Victoza; Xultophy | Liraglutide | 09/24/2024 | 68:20.06 - Incretin Mimetics | 68:20.06 - Incretin Mimetics; 28:20.08.92 - Anorexigenic Agents, Miscellaneous |
| Intron A | Interferon Alfa (Antineoplastic) | 09/24/2024 | 10:00 - Antineoplastic Agents; 8:18.20 - Interferons | 10:00 - Antineoplastic Agents; 8:18.20 - Interferons; 90:04.12 - Interferons |
| Solu-CORTEF; Cortef; A-hydroCort | Hydrocortisone | 09/24/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 52:08.08 - Corticosteroids; 84:06.08 - Corticosteroids |
| Acetasol HC Otic Solution; Antibiotic Otic Solution; Antibiotic Otic Suspension; Ocu-Cort; VoSol HC Otic Solution | hydrocortisone (EENT) | 09/24/2024 | 52:08.08 - Corticosteroids | 52:08.08 - Corticosteroids; 68:04 - Adrenals; 84:06.08 - Corticosteroids |
| Ala-Cort®, Anucort-HC®, Anusert-HC®, Anusol-HC®, Cetacort®, Cortizone®, Dermacort®, Lanacort®, Proctocort®, Sarnol-HC | hydrocortisone (Topical) | 09/24/2024 | 84:06.08 - Corticosteroids | 84:06.08 - Corticosteroids; 52:08.08 - Corticosteroids; 68:04 - Adrenals |
| Flonase Nasal Spray | Fluticasone | 09/24/2024 | 52:08.08 - Corticosteroids | 52:08.08 - Corticosteroids; 68:04 - Adrenals; 48:10.08 - Corticosteroids |
| Gelato Home-care (keystone); Gel-Kam, Just for Kids; OMNI Gel; Fluoridex; PerioMed; Stance | Fluorides | 09/24/2024 | 34:04 - Nutritional supplement | 34:04 - Nutritional supplement; 92:28 - Cariostatic Agents |
| Synalar; Lidex | Fluocinolone | 09/24/2024 | 84:06.08 - Corticosteroids | 84:06.08 - Corticosteroids; 52:08.08 - Corticosteroids |
| Pepcid | Famotidine | 09/24/2024 | 56:28.12 - Histamine H2-Antagonists | 56:28.12 - Histamine H2-Antagonists; 4:92 - Other Antihistamines |
| Necon; Norinyl; Ortho-Novum; NuvaRing; Ortho Evra; Tri-Levlen 21; Ovral | Estrogen-Progestin Combinations | 09/24/2024 | 68:12 - Contraceptives | 68:12 - Contraceptives; 68:32 - Progestins; 68:16.04 - Estrogens; 68:18.04 - Antigonadotropins |
| Activella; Alora; Angeliq; Climara; Climara Pro; Elestrin; Vivelle; Vagifem | Estradiol | 09/24/2024 | 68:16.04 - Estrogens | 68:16.04 - Estrogens; 92:24 - Bone Resorption Inhibitors |
| Benzamycin; Erythromycin and Benzoyl Peroxide Gel | Erythromycin (Topical) | 09/24/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 52:04.04 - Antibacterials; 8:12.12.04 - Erythromycins |
| DDAVP; Minirin; Stimate Nasal Spray | Desmopressin | 09/24/2024 | 68:28 - Pituitary | 68:28 - Pituitary; 20:28.16 - Hemostatics |
| Danazol | 09/24/2024 | 68:08 - Androgens | 68:08 - Androgens; 68:18.04 - Antigonadotropins | |
| Gengraf; Neoral; SandIMMUNE | cycloSPORINE | 09/24/2024 | 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous | 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous; 52:08 - Anti-inflammatory Agents |
| BenzaClin; Duac | Clindamycin | 09/24/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:12.28.20 - Lincomycins |
| Tagamet | Cimetidine | 09/24/2024 | 56:28.12 - Histamine H2-Antagonists | 56:28.12 - Histamine H2-Antagonists; 4:92 - Other Antihistamines |
| Fortical®, Miacalcin® | Calcitonin | 09/24/2024 | 68:24.04 - Antiparathyroid Agents | 68:24.04 - Antiparathyroid Agents; 92:24 - Bone Resorption Inhibitors |
| Zynrelef | Bupivacaine and Meloxicam | 09/24/2024 | 72:00 - Local Anesthetics; 28:08.04.92 - Nonsteroidal Anti-inflammatory Agents, Miscellaneous | 72:00 - Local Anesthetics; 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Celestone Soluspan | Betamethasone | 09/24/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 84:06.08 - Corticosteroids |
| Alphatrex®, Betatrex®, Beta-Val®, Diprolene®, Luxiq®, Maxivate® | Betamethasone (Topical) | 09/24/2024 | 84:06.08 - Corticosteroids | 84:06.08 - Corticosteroids; 68:04 - Adrenals |
| Solarcaine; Rhulicream; Outgro; Ivarest | Benzocaine (Topical) | 09/24/2024 | 84:08 - Antipruritics and Local Anesthetics | 84:08 - Antipruritics and Local Anesthetics; 52:16 - Local Anesthetics |
| Neosporin | Bacitracin (Topical) | 09/24/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 52:04.04 - Antibacterials |
| Scenesse | Afamelanotide | 09/24/2024 | 68:48 - Melanocortin Receptor Agonists | 68:48 - Melanocortin Receptor Agonists; 92:56 - Protective Agents; 84:80 - Sunscreen Agents |
| Zovirax | Acyclovir (Topical) | 09/24/2024 | 84:04.06 - Antivirals | 84:04.06 - Antivirals; 8:18.32 - Nucleosides and Nucleotides |
| Chantix | Varenicline | 08/28/2024 | 12:02 - Smoking Cessation Agents | 12:02 - Smoking Cessation Agents; 52:92 - EENT Drugs, Miscellaneous |
| Tezspire | Tezepelumab-ekko | 08/28/2024 | 48:10.20 - Interleukin Antagonists | 48:10.20 - Interleukin Antagonists; 8:18.24 - Monoclonal Antibodies |
| Advair Diskus; Advair HFA; AirDuo RespiClick | Salmeterol | 08/28/2024 | 12:12.08.12 - Selective beta-2-Adrenergic Agonists | 12:12.08.12 - Selective beta-2-Adrenergic Agonists; 48:12.04.12 - Selective beta-2-Adrenergic Agonists |
| Compazine; Compro | Prochlorperazine | 08/28/2024 | 28:16.08.24 - Phenothiazines | 28:16.08.24 - Phenothiazines; 56:22.08 - Antihistamines |
| Dilantin; Phenytek | Phenytoin | 08/28/2024 | 28:12.12 - Hydantoins | 28:12.12 - Hydantoins; 24:04.04.08 - Class Ib Antiarrhythmics |
| Nayzilam; Seizalam | Midazolam | 08/28/2024 | 28:24.08 - Benzodiazepines | 28:24.08 - Benzodiazepines; 28:12.08 - Benzodiazepines |
| Mircera | Methoxy Polyethylene Glycol-Epoetin Beta | 08/28/2024 | 20:16 - Hematopoietic Agents | 20:16 - Hematopoietic Agents; 20:04 - Antianemia Drugs |
| Orkambi | Lumacaftor and Ivacaftor | 08/28/2024 | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors; 48:14.12 - Cystic Fibrosis Transmembrane Conductance Regulator Potentiators |
| Alferon N; Intron A | Interferon Alfa | 08/28/2024 | 8:18.20 - Interferons | 8:18.20 - Interferons; 10:00 - Antineoplastic Agents; 90:04.12 - Interferons |
| Anx; Atarax; Vistaril | hydrOXYzine | 08/28/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous; 4:92 - Other Antihistamines; 4:04 - First Generation Antihistamines | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous; 4:04 - First Generation Antihistamines |
| Ocufen | Flurbiprofen Sodium (EENT) | 08/28/2024 | 52:08.20 - Nonsteroidal Anti-inflammatory Agents | 52:08.20 - Nonsteroidal Anti-inflammatory Agents; 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Retisert; Yutiq | Fluocinolone | 08/28/2024 | 52:08.08 - Corticosteroids | 52:08.08 - Corticosteroids; 84:06.08 - Corticosteroids |
| Nasalide; Nasarel | Flunisolide | 08/28/2024 | 52:08.08 - Corticosteroids | 52:08.08 - Corticosteroids; 48:10.08 - Corticosteroids; 68:04 - Adrenals |
| Romycin | Erythromycin | 08/28/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.12.04 - Erythromycins; 84:04.04 - Antibacterials |
| Inspra | Eplerenone | 08/28/2024 | 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 24:36.16 - Potassium-sparing Diuretics; 40:28.16 - Potassium-sparing Diuretics; 24:08.44.20 - Mineralocorticoid (Aldosterone) Receptor Antagonists | 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 24:36.16 - Potassium-sparing Diuretics; 40:28.16 - Potassium-sparing Diuretics |
| Epinal | EPINEPHrine (Mydriatic) | 08/28/2024 | 52:24 - Mydriatics | 52:24 - Mydriatics; 52:40.92 - Antiglaucoma Agents, Miscellaneous; 12:12.12 - alpha- and beta-Adrenergic Agonists; 48:12.04.16 - alpha- and beta-Adrenergic Agonists; 52:32 - Vasoconstrictors |
| Adrenalin | EPINEPHrine (Vasoconstrictor) | 08/28/2024 | 52:32 - Vasoconstrictors | 52:32 - Vasoconstrictors; 12:12.12 - alpha- and beta-Adrenergic Agonists; 48:12.04.16 - alpha- and beta-Adrenergic Agonists; 52:24 - Mydriatics; 52:40.92 - Antiglaucoma Agents, Miscellaneous |
| S2 | EPINEPHrine | 08/28/2024 | 12:12.12 - alpha- and beta-Adrenergic Agonists; 48:12.04.16 - alpha- and beta-Adrenergic Agonists | 12:12.12 - alpha- and beta-Adrenergic Agonists; 48:12.04.16 - alpha- and beta-Adrenergic Agonists; 52:24 - Mydriatics; 52:32 - Vasoconstrictors; 52:40.92 - Antiglaucoma Agents, Miscellaneous |
| Elestat | Epinastine | 08/28/2024 | 52:02 - Antiallergic Agents | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines |
| Atridox | Doxycycline | 08/28/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 84:04.04 - Antibacterials |
| Zerviate | Cetirizine | 08/28/2024 | 52:02 - Antiallergic Agents | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines; 48:04.08 - Second Generation Antihistamines |
| Wellbutrin; Zyban | buPROPion | 08/28/2024 | 28:16.04.92 - Antidepressants, Miscellaneous | 28:16.04.92 - Antidepressants, Miscellaneous; 12:02 - Smoking Cessation Agents |
| Bepreve | Bepotastine | 08/28/2024 | 52:02 - Antiallergic Agents | 52:02 - Antiallergic Agents; 4:92 - Other Antihistamines |
| Beconase AQ Nasal Spray | Beclomethasone | 08/28/2024 | 52:08.08 - Corticosteroids; 48:10.08 - Corticosteroids | 52:08.08 - Corticosteroids; 48:10.08 - Corticosteroids; 68:04 - Adrenals |
| Neosporin Ophthalmic Ointment | Bacitracin | 08/28/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 84:04.04 - Antibacterials |
| Astelin Nasal Spray; Optivar | Azelastine | 08/28/2024 | 52:02 - Antiallergic Agents; 48:04.08 - Second Generation Antihistamines | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines |
| Atropine Care 1%; Isopto Atropine | Atropine (ophthalmic) | 08/28/2024 | 52:24 - Mydriatics | 52:24 - Mydriatics; 12:08.08 - Antimuscarinics/Antispasmodics; 48:12.08 - Anticholinergic Agents; 91:00 - Antidote Therapeutics |
| Aggrenox; Alka Seltzer Morning Relief; Alka-Seltzer Effervescent Pain Reliever and Antacid; Alka-Seltzer Extra Strength Effervescent Pain Reliever and Antacid; Alka-Seltzer Lemon-Lime Effervescent Pain Reliever and Antacid; Anacin; Ascriptin Arthritis Pai | Aspirin | 08/28/2024 | 28:08.04.24 - Salicylates; 20:12.20 - Thrombolytic Agents; 20:12.18 - Platelet-aggregation Inhibitors | 28:08.04.24 - Salicylates; 20:12.18 - Platelet-aggregation Inhibitors |
| Gocovri; Osmolex ER | Amantadine | 08/28/2024 | 28:36.04 - Adamantanes | 28:36.04 - Adamantanes; 8:18.04 - Adamantanes; 12:08.04 - Antiparkinsonian Agents |
| Lastacaft | Alcaftadine | 08/28/2024 | 52:02 - Antiallergic Agents | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines |
| Diamox | acetaZOLAMIDE | 08/28/2024 | 52:40.12 - Carbonic Anhydrase Inhibitors | 52:40.12 - Carbonic Anhydrase Inhibitors; 24:36.04 - Carbonic Anhydrase Inhibitors; 28:12.92 - Anticonvulsants, Miscellaneous; 40:28.04 - Carbonic Anhydrase Inhibitors |
| Clear Eyes ACR; Visine A.C. | Zinc Sulfate | 08/28/2024 | 52:04.92 - Anti-infectives, Miscellaneous | 40:12 - Replacement Preparations |
| Gelato Home-care (keystone); Gel-Kam, Just for Kids; OMNI Gel; Fluoridex; PerioMed; Stance | Fluorides | 08/28/2024 | 34:00 - Dental Agents | 34:04 - Nutritional supplement |
| Romazicon | Flumazenil | 08/28/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 91:32.04 - GABA-mediated Benzodiazepine Antidotes |
| Genosyl; INOmax | Nitric Oxide | 08/28/2024 | 24:08.08 - Nitrates and Nitrites | 48:48.92 - Vasodilating Agents, Miscellaneous; 24:08.08 - Nitrates and Nitrites |